Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 13.70
-0.12 (-0.87%)
May 13, 2025, 1:44 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 41.39 billion as of May 12, 2025. Its market cap has increased by 18.79% in one year.
Market Cap
41.39B
Enterprise Value
45.58B
Revenue
13.62B
Ranking
n/a
PE Ratio
20.66
Stock Price
13.70
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 41.39B, an increase of 391.43%. That is a compound annual growth rate of 28.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 117.99B |
| WuXi Biologics | 93.82B |
| Innovent Biologics | 86.44B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |